Dorothee Selimoglu-Buet
Overview
Explore the profile of Dorothee Selimoglu-Buet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
486
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Droin N, Lucas N, Parinet V, Selimoglu-Buet D, Humbert M, Saada V, et al.
Leuk Lymphoma
. 2017 Jun;
58(12):2875-2879.
PMID: 28593791
Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic disorder that associates dysplastic and proliferative features. Tissue inflammatory disorders occur in a fraction of CMML patients during the course of their...
22.
Merlevede J, Droin N, Qin T, Meldi K, Yoshida K, Morabito M, et al.
Nat Commun
. 2016 Feb;
7:10767.
PMID: 26908133
The cytidine analogues azacytidine and 5-aza-2'-deoxycytidine (decitabine) are commonly used to treat myelodysplastic syndromes, with or without a myeloproliferative component. It remains unclear whether the response to these hypomethylating agents...
23.
Obba S, Hizir Z, Boyer L, Selimoglu-Buet D, Pfeifer A, Michel G, et al.
Autophagy
. 2015 Jun;
11(7):1114-29.
PMID: 26029847
Autophagy is induced during differentiation of human monocytes into macrophages that is mediated by CSF1/CSF-1/M-CSF (colony stimulating factor 1 [macrophage]). However, little is known about the molecular mechanisms that link...
24.
Selimoglu-Buet D, Wagner-Ballon O, Saada V, Bardet V, Itzykson R, Bencheikh L, et al.
Blood
. 2015 Apr;
125(23):3618-26.
PMID: 25852055
Chronic myelomonocytic leukemia (CMML) is a myelodysplastic syndrome/ myeloproliferative neoplasm whose diagnosis is currently based on the elevation of peripheral blood monocytes to >1 × 10(9)/L, measured for ≥3 months....
25.
Meldi K, Qin T, Buchi F, Droin N, Sotzen J, Micol J, et al.
J Clin Invest
. 2015 Mar;
125(5):1857-72.
PMID: 25822018
Myelodysplastic syndromes and chronic myelomonocytic leukemia (CMML) are characterized by mutations in genes encoding epigenetic modifiers and aberrant DNA methylation. DNA methyltransferase inhibitors (DMTis) are used to treat these disorders,...
26.
Selimoglu-Buet D, Solary E
Curr Hematol Malig Rep
. 2014 Aug;
9(4):301-10.
PMID: 25142910
Chronic myelomonocytic leukemia is a clonal malignancy of the ageing hematopoietic stem cell characterized by a biased differentiation leading to persistent monocytosis and inconstant hypersensitivity of myeloid progenitors to granulo-monocyte...
27.
Selimoglu-Buet D, Gallais I, Denis N, Guillouf C, Moreau-Gachelin F
PLoS One
. 2012 Nov;
7(11):e49052.
PMID: 23145067
Oncogenic mutations leading to persistent kinase activities are implicated in various human malignancies. Thereby, signaling pathway-targeted therapies are powerful customized treatment to eradicate cancer cells. In murine and human leukemia...